The Epithelium Takes Center Stage in Allergic Keratoconjunctivitis
Authors:
- Akira MatsudaAMAkira Matsuda
- Takahiko SetoTSTakahiko Seto
- Kaori OhtomoKOKaori Ohtomo
- Toshinari FunakiTFToshinari Funaki
- Toshiro TakaiTTToshiro Takai
- Akira MurakamiAMAkira Murakami
- 1 November 2010
- journal article
- Published by Wolters Kluwer Health in Cornea
- Vol. 29 (11) , S41-S47
Abstract
To investigate the role of the epithelium in severe allergic conjunctivitis. We first investigated the expression of protease-activated receptors (PARs) in cultured human conjunctival epithelial cells and fibroblasts by reverse transcription-polymerase chain reaction. Next, we examined whether mite allergen-stimulated cells release chemokines and whether physiological protease inhibitors such as secretory leukocyte protease inhibitor (SLPI) and α1-antitrypsin can inhibit their production. We also looked at the expression of thymic stromal lymphopoietin (TSLP) in giant papillae of patients with vernal keratoconjunctivitis and examined whether the as Toll-like receptor 3 ligand polyinosinic:polycytidylic acid (poly I:C) can induce expression of TSLP in cultured human conjunctival epithelial cells. PAR 1, PAR2, and PAR3 were expressed in cultured human conjunctival epithelial cells and fibroblasts at mRNA level. These epithelial cells released interleukin (IL) 6 and IL-8, with an upregulation in their gene expression, in response to the serine protease activity of mite allergens. This response was inhibited by SLPI and α1-antitrypsin. Transforming growth factor β1 decreased the production of SLPI in corneal and conjunctival epithelial cells. TSLP was expressed in giant papillae epithelium in patients with vernal keratoconjunctivitis at mRNA and protein levels. Poly I:C induced expression of TSLP in cultured conjunctival epithelial cells at mRNA level. Costimulation with TSLP and IL-33 had a synergistic effect for IL-13 mRNA expression in cultured human mast cells. Imbalance between protease of mite allergens and innate protease inhibitors of the epithelium may induce inflammation and disrupt barrier function. Viral infection may induce expression of TSLP via Toll-like receptors and release IL-33 by necrosis. These phenomena promote excessive allergic reactions; hence, the epithelium takes "center stage" in allergic conjunctivitis.Keywords
This publication has 9 references indexed in Scilit:
- Functional Role of Thymic Stromal Lymphopoietin in Chronic Allergic KeratoconjunctivitisInvestigative Ophthalmology & Visual Science, 2010
- The Role of Interleukin-33 in Chronic Allergic ConjunctivitisInvestigative Ophthalmology & Visual Science, 2009
- Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic CaspasesImmunity, 2009
- The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1Proceedings of the National Academy of Sciences, 2009
- SLPI prevents cytokine release in mite protease-exposed conjunctival epithelial cellsBiochemical and Biophysical Research Communications, 2009
- Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsJournal of Experimental Medicine, 2007
- γ-Secretase-mediated proteolysis in cell-surface-receptor signallingNature Reviews Molecular Cell Biology, 2002
- Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLPNature Immunology, 2002
- Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluidCurrent Eye Research, 1998